According to Pharming Group's latest financial reports the company's current revenue (TTM ) is HK$2.22 Billion. In 2023 the company made a revenue of HK$1.91 Billion an increase over the revenue in the year 2022 that were of HK$1.60 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | HK$2.22 B | 16.38% |
2023 | HK$1.91 B | 19.26% |
2022 | HK$1.60 B | -11.45% |
2021 | HK$1.81 B | -12.01% |
2020 | HK$2.06 B | 24.93% |
2019 | HK$1.65 B | 15.97% |
2018 | HK$1.42 B | 45.74% |
2017 | HK$0.97 B | 590.41% |
2016 | HK$0.14 B | 38.72% |
2015 | HK$0.10 B | -58.84% |
2014 | HK$0.24 B | 156.08% |
2013 | HK$96.74 M | -32.51% |
2012 | HK$0.14 B | 244.34% |
2011 | HK$41.63 M | 863.9% |
2010 | HK$4.31 M | -74.71% |
2009 | HK$17.08 M |